Camber Pharmaceuticals Announces Addition of Phenylephrine Hydrochloride Injection, USP

Camber Pharmaceuticals is excited to announce the addition of Phenylephrine Hydrochloride Injection, USP to their portfolio.

Phenylephrine Hydrochloride Injection, USP is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Phenylephrine Hydrochloride Injection, USP are available in:

• 10 mg/mL | 25 x 1 mL Single-Dose Vials
• 50 mg/5 mL (10 mg/mL) | 10 x 5 mL Vials
• 100 mg/10 mL (10 mg/mL) | 10 mL Vial

To find out more information on Phenylephrine Injection, USP , please visit: www.camberpharma.com/phenylephrine